文献速递腹部介入CTMRDSA

促进未来肝剩余增生以推动手术切除

Promoting Surgical Resection through Future Liver Remnant Hypertrophy.
PubMed 文献 · Radiographics · 2022-10-07

综述指出未来肝剩余(FLR)不足会阻碍原发性或继发性肝脏恶性肿瘤的根治性手术。正常肝功能且无危险因素者需FLR达20%,接受全身化疗者需>30%,肝硬化者需>40%。综述了门静脉结扎、门静脉栓塞、放射肝叶切除、肝静脉剥夺及联合肝脏分隔和门静脉结扎的二步肝切除等技术,强调各自优缺点。

要点

  • FLR需求因基线肝功能而异:正常20%,化疗后>30%,肝硬化>40%。
  • 多种介入和外科技术可促进FLR增生,选择需个体化评估。
  • 了解各技术优缺点有助于为患者选择合适方案。

核心结论

  • FLR不足可通过多种介入或外科技术促进增生,从而推动根治性手术切除。

研究设计与样本

  • 综述类文章,总结了促进FLR增生的技术,重点讨论技术考量、结局及优缺点。

诊断标准与关键数值

  • 正常基线肝功能且无危险因素者需FLR达20%以维持术后肝功能。
  • 接受全身化疗者FLR需>30%。
  • 肝硬化者FLR需>40%。

临床应用与阅片要点

  • 临床需根据患者化疗史和肝硬化程度评估FLR阈值,选择合适增生技术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

An inadequate future liver remnant (FLR) can preclude curative-intent surgical resection for patients with primary or secondary hepatic malignancies. For patients with normal baseline liver function and without risk factors, an FLR of 20% is needed to maintain postsurgical hepatic function. However, the FLR requirement is higher for patients who are exposed to systemic chemotherapy (FLR, >30%) or have cirrhosis (FLR, >40%). Interventional radiologic and surgical methods to achieve FLR hypertrophy are evolving, including portal vein ligation, portal vein embolization, radiation lobectomy, hepatic venous deprivation, and associating liver partition and portal vein ligation for staged hepatectomy. Each technique offers particular advantages and disadvantages. Knowledge of these procedures can help clinicians to choose the suitable technique for each patient. The authors review the techniques used to develop FLR hypertrophy, focusing on technical considerations, outcomes, and the advantages and disadvantages of each approach. Online supplemental material is available for this article. ©RSNA, 2022.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Entezari, Toskich, Kim, et al. Promoting Surgical Resection through Future Liver Remnant Hypertrophy. Radiographics. 2022. PMID: 36206182. doi:10.1148/rg.220050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。